Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD

Dr Ross described how genomic reports may need to be updated to account for new insights into a variant's role in cancer.

from Latest articles from Cancer Therapy Advisor Brain Cancer https://ift.tt/2yZIVh6